Shenyang Xingqi Pharmaceutical Co.,Ltd. (SHE:300573)

SHE:300573 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 2, 2026	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	16,742	12,229	22,715	11,076	11,263	7,612
Market Cap Growth	42.87%	-46.16%	105.08%	-1.66%	47.96%	29.71%
Enterprise Value	16,497	11,973	22,352	10,579	11,226	7,679
Last Close Price	67.94	48.70	89.40	43.39	47.03	32.62
PE Ratio	25.87	36.17	94.63	52.33	57.85	86.52
PS Ratio	6.95	6.29	15.48	8.86	10.96	11.05
PB Ratio	9.01	7.68	13.44	7.14	8.38	10.97
P/TBV Ratio	9.78	8.38	14.09	7.27	8.52	11.56
P/FCF Ratio	40.89	56.03	408.51	-	53.15	543.47
P/OCF Ratio	26.33	29.33	71.53	38.69	36.69	62.32
EV/Sales Ratio	6.85	6.16	15.23	8.46	10.92	11.15
EV/EBITDA Ratio	18.82	23.95	65.68	35.59	37.73	48.73
EV/EBIT Ratio	21.47	29.32	85.99	45.76	46.72	68.51
EV/FCF Ratio	40.29	54.85	401.97	-	52.98	548.27
Debt / Equity Ratio	0.07	0.14	0.05	0.01	0.08	0.12
Debt / EBITDA Ratio	0.15	0.42	0.23	0.05	0.36	0.51
Debt / FCF Ratio	0.33	0.99	1.42	-	0.53	5.71
Asset Turnover	1.05	0.94	0.77	0.72	0.78	0.76
Inventory Turnover	2.96	2.93	2.64	2.52	2.85	2.54
Quick Ratio	1.51	1.41	2.83	4.69	3.23	0.94
Current Ratio	1.90	1.80	3.48	5.68	3.69	1.39
Return on Equity (ROE)	37.08%	20.59%	14.81%	14.62%	20.52%	14.73%
Return on Assets (ROA)	20.85%	12.30%	8.54%	8.33%	11.33%	7.71%
Return on Invested Capital (ROIC)	41.91%	25.63%	20.13%	23.01%	27.40%	15.12%
Return on Capital Employed (ROCE)	40.00%	24.50%	14.70%	14.20%	16.90%	14.90%
Earnings Yield	3.86%	2.76%	1.06%	1.91%	1.73%	1.16%
FCF Yield	2.45%	1.79%	0.24%	-0.12%	1.88%	0.18%
Dividend Yield	1.14%	2.20%	2.11%	1.26%	0.50%	0.28%
Payout Ratio	68.05%	138.01%	74.36%	38.19%	24.21%	18.41%
Buyback Yield / Dilution	-0.66%	-0.70%	-0.96%	-7.45%	0.30%	-2.88%
Total Shareholder Return	0.48%	1.50%	1.15%	-6.19%	0.80%	-2.60%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.